INTRODUCTION
Fetal liver contains hematopoietic and mesenchymaI ceils in addition to hepatic parenchymal cells. Culture conditions would be expected to favor survival of certain of these cell types at the expense of others (3) . In order to study the survival of hepadc parenchymal cells in culture, a marker that is specific for differentiated parenchymal cells is highly-desirable (5, 12) Morphologic characterization is obviously inadequate. Although histochemical localization of intracellular enzymes or glycogen may be helpfuI, such markers are often nonspecific and require sacrifice of the cells. Albumin, on the other hand, is a secreted protein and is thought to be synthesized exclusively in hepatic parenchymal cells in wvo (8) In the present report, a radioimmunoassay for human albumin is described and utilized to monitor albumin production by human fetal liver in monolayer culture.
I~IATERIALS AND I~IETHODS

Tissue Culture
The cultivation of primary human emb~youic liver is reported elsewhere (9) The culture medium was that of Leibovitz (L-15, Microbiological Assomates, Inc., Bethesda, Md) supplemented with 0042% argmine (HC1), 0.03% glutaminc (Microbiological Associates, Inc ), 0.1% dextrose, potassium penicillin G, 150 pg/ml, streptomycin sulfate, 250 pg/ml, and 10% fetal calf serum (FCS) (Flow" Laboratories, Ine., Rockeville, Md.). Inocula of 5 X 10 ~ cells in 0.5 ml of medium were seeded into 16 X 100 mm constricted glass tubes (Rochester Scientific Co., Rochester, N. Y.) and incubated in air. The resulting cell growth was washed with medium after 2 days and cultivated a further 3 or more days before the medium was assayed for human albumin. The number of apparent hepatic parenchymal ceils between 3 and 10 days of culture was appro~mately constant by direct cell counts of stained preparations.
A cell hue composed of fibroblasts morphologicaUy was derived from a liver culture that appeared to be overrun with fibroblasts on iuitiaI passage. The line was maintained in the standard growth medium and continued to resemble fibroblasts, with passage by trypsinization every three or four weeks HeLa cells, human muscle-skin fibroblasts, and mouse "L" cells were similarly maintained. Because liver parenchymaI cells in monolayer generally survived poorly after passage, they were studied in primary culture only.
Cellulose-Conjugated Antibody and RadiolabeIed Albumin
Bromoacctyl cellulose (BAC) was prepared as described by Robbms ct al (11), and sheep antihuman albumin (Calbiochem, Los Angeles, Calif.) was conjugated to BAC by the method of Mann et al (6) . Human albumin (grade III, Sigma Chemical Co., St. Louis, Mo.) was labeled in the presence of 1.0 mCi Na-l"-sI (New England Nuclear Corp., Boston, Mass.) (7) The labeled albumin was freed of unreacted 1~5I by dialysis against several liters of 0.14 ~f saline at 4°C and bad an initial spemfic activity of 0.4 mCi/mg° Of the radioactivity in the final preparauon, 92 °To was precipitable by antialbumi_n. Dilutlon of BAC-AB ~OVRE 1 Titration of BAC-antibody. Albumiu-125I, 0.13 #g (3000-5000 cpm), was incubated in duplicate with serial dilutions of BAC-antihuman albumin in VBS, as described elsewhere (6) . After pelleting of the BAC-antibody with bound albumin-t25I, snpernatant radioactivity was determined in a well-type scintillation counter
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T h e titration of BAC-antibody against a standard quantity of albumin-1:sI is represented in Fig. 1 . A n a m o u n t of BAC-antibody that bound approximately 5 0 % of the added labeled albumin was chosen for the standard assay W h e n this a m o u n t of BAC-antibody and the standard quantity of albumin-12~I were incubated with unlabeled albumin, label was displaced to the supernatant. T h e amount of label displaced was proportional to the amount of unlabeled albumin present, when this was in the range 0.05-0.50 #g (Fig. 2) , and the resulting curve served as a reference for assay of unknown samples. Because it appeared that the assay was most accurate in a narrower range (0.08-0 20 #g), unknowns were assayed until a reading on this portion of the reference curve was obtained.
Volumes of culture medium up to 0.4 ml were assayed without affecting accuracy (6) .
Dilutions of whole h u m a n serum with comparable amounts of albumin gave a displacement curve that was essentially identical to the reference curve (Fig. 2) Because the culture medium usually contained 10% fetal calf serum, bovine albumin was also assayed. It showed no significant crossreactivity, however, over the range present (0. I -0.5 rag) in the sample volumes usually assayed. 
T h e c u l t u r e s were g r o w n as described in M a t e r i a l s a n d M e t h o d s . Liver cell cultures c o n t a i n e d either lV~ h u m a n s e r u m (HS) or 10~0 fetal calf s e r u m (FCS). At d a y 2, the cultures were w a s h e d a n d t h e n i n c u b a t e d in M E M --L, s u p p l e m e n t e d w i t h g l u t a m i n e ,
antibiotics, as above, a n d 1.0 /~Ci/ml leucine-14C. After 3 or 5 days of f u r t h e r i n c u b ation, 0.2 ml of c u l t u r e m e d i u m was t a k e n for assay of albumin-14C. T h e s a m p l e was treated initially with a nonspecific B A C c o n j u g a t e (to g u i n e a pig s e r u m protein) to r e m o v e e x t r a n e o u s labeled material, w h i c h was pelleted by c e n t r i f u g a t i o n at 1500 g for 20 m l n (6) a n d w a s h e d once. T h e c o m b i n e d s u p e r n a t a n t s were d i v i d e d b e t w e e n two tubes, each c o n t a i n i n g B A C -a n t i a l b u m i n . U n l a b e l e d a l b u m i n was a d d e d in excess (100 ~g) to one t u b e of each pair, the final v o l u m e s were a d j u s t e d to 0.5 ml with VBS, a n d the tubes were s h a k e n for 3 h r at r o o m t e m p e r a t u r e . After centrifugation, the BACa n t The albumin produced by cultures of five different human fetal livers is shown in Table I . The time course of such production is presented elsewhere (2) Neither the culture medium nor cell lysates of various other ceils contained detectable albumin.
The data of Table I suggest that de novo synthesis of albumin is occurring, in that the albumin secreted, over the period tested, exceeds by 50-200 % the amount of albumin in the initial ceil inoculum (see legend to Table I ). Moreover, albumin secretion during the first two days in culture has been disregarded. Further evidence for the de novo production of albumin was the incorporation by liver cell cultures of a labeled amino acid precursor into secreted albumin. Electrophoresis of media from liver cell cultures that had been incubated with leucine-~4C demonstrated a peak of radioactivity migrating with albumin. The medium from simi- Table II . The liver cell medium, with added cold leucine and carrier albumin (~00 #g), was dialyzed against isotonic saline and then concentrated g0-fold with respect to the volume of the initial sample. IteLa cell medium was treated similarly for a ~o00-fold concentrate. Each concentrate was electrophoresed on cellulose acetate strips in 0.05 M Trisbarbital buffer, pit 8.8, at 1.5 v/cm for ~ hr. The strips were assayed for radioactivity in a gas-flow scanner (Tracerlab, Waltham, Mass.) and compared to a reference electrophoresls of normal human sernm stained for protein which demonstrated the portion of serum albumin (ALB) and globulins (at, ~e, ~, and 3')-Bold line, liver cell medium; light line, HeLa medium.
larly treated HeLa cell cultures gave no such peak (Fig 3) . The albumin-14C of liver cell cultures could also be measured immunologmally through its ability to reversibly complex with specific BACantibody. No albumin-Z4C was found in media from fibroblast and HeLa cultures treated in a similar fashion (Table II) . Moreover, in the liver cultures, immunologically measurable albumin-14C increased with time to the same extent that total secreted albumin increased, as measured by the standard radioimmunoassay. Because the intraceUular pools of albumin and leucine were unknown, a quantitative comparison of total albumin secretion and de novo synthesis was not possible. The data suggest, however, that secretion and synthesis closely parallel one another in liver cell cultures.
DISCUSSION
Albumin secretion by cultures of rat hepatoma cells has been demonstrated previously by immunoprecipitation of newly labeled albumin (9) and by complement fixation (I0). Both techniques, however, are more laborious and generally less sensitive than the present method. The coupling of antibody to BAC renders the antibody insoluble and thereby avoids the time-consuming precipitation steps of other radioimmunoassays, a run of several dozen tubes can be completed in less than 4 hr. Its sensitivity, like that of other radioimmaunoassays, depends primarily on the specific activity of the labeled albumin. The sensitivity of the present assay proved to be particularly convenient since the albumin of most cultures could be measured without extensive dilution of the unknown sample. The incorporation of labeled precursor into albumin by fetaI liver was first demonstrated several years ago with liver slices and indicates that human fetal liver is capable of albumin synthesis (4) . The specificity of this function for hepatocytes in culture, however, has been questioned with the report of albumin synthesis by HeLa cells (1) . We have been unable to detect albumin in cultures of similar ceils (Tables I and II) ; if albumin is produced by HeLa cells, the amount appears to be two or more orders of magnitude less than that produced by hepatic parenchymal cells in primary culture. The parenchymal cells appear, moreover, to be solely responsible for the albumin measured, since the amount secreted correlates well with the apparent extent of parenchymal cell growth in a mixed culture of human embryonic liver and with other indications of parenchvmal cell differennation (2) Albumin secretion, therefore, may be particularly useful for evaluating parenchymal cell survival and differennatmn in tissue culture of embryonic hver.
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